Texas Oncology -P.A.- Mesquite — Mesquite, Texas

Texas Oncology -P.A.- Mesquite is a clinical research site located in Mesquite, Texas, United States 75150.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Texas Oncology -P.A.- Mesquite has participated in 1 clinical trials.

Therapeutic areas: Chronic Lymphocytic Leukemia (CLL).

Sponsors: Pharmacyclics LLC..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Mesquite

Browse all research sites in Texas · View every site in Mesquite

• SMS Clinical Research
• Southwest Rheumatology Research
• Southern Endocrinology Associates
• Research Site
• Novartis Investigative Site
• Texas Cancer Center of Mesquite
• Pfizer Investigational Site
• Novo Nordisk Investigational Site
• Investigational Site Number 840074
• GSK Investigational Site
• Southern Endocrinology Associates PA
• Southwest Rheumatology

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology -P.A.- Mesquite?

Texas Oncology -P.A.- Mesquite has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology -P.A.- Mesquite conducted?

Texas Oncology -P.A.- Mesquite has 1 clinical trials on record. Their work covers Chronic Lymphocytic Leukemia (CLL).

Is Texas Oncology -P.A.- Mesquite accredited by Crixeo Clinical Trials?

Texas Oncology -P.A.- Mesquite has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology -P.A.- Mesquite?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.